Bristol-Myers Squibb (BMY), AbbVie (ABBV) Announce Receipt of Positive CHMP Opinion for Empliciti as Multiple Myeloma Treatment
Tweet Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) and AbbVie (NYSE: ABBV) announced that the Committee for Medicinal Products for Human Use (CHMP) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
